Trinity Biotech (TRIB) Tax Provisions (2009 - 2024)
Trinity Biotech (TRIB) posted quarterly Tax Provisions of -$585000.0 for Q4 2024, down 19600.0% year-on-year from N/an in Q1 2024, and down 1771.43% on a QoQ basis from $35000.0 in Q3 2024.
Trinity Biotech (TRIB) Tax Provisions (2009 - 2024) Analysis & Trends
Trinity Biotech (TRIB) has reported Tax Provisions for 16 consecutive years, with -$585000.0 the latest figure, recorded in Q4 2024.
- Quarterly Tax Provisions fell 19600.0% year-over-year to -$585000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$486000.0 (down 923.73% YoY) and the FY2025 annual result came in at $199000.0, down 59.05% from the prior year.
- Tax Provisions declined to -$585000.0 in Q4 2024 per TRIB's latest filing, from $35000.0 in the prior quarter.
- Over the last five years, Tax Provisions for TRIB reached as high as $1.2 million in Q4 2021 and fell as low as -$655000.0 in Q2 2021.
- A 5-year average of $6550.0 and a median of $3000.0 in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2023 — Tax Provisions surged 734.38% — and 2024, when it sank 19600.0%.
- Year by year, Tax Provisions stood at $730000.0 in 2020, then jumped by 62.88% to $1.2 million in 2021, then sank by 98.91% to $13000.0 in 2022, then tumbled by 76.92% to $3000.0 in 2023, then plunged by 19600.0% to -$585000.0 in 2024.
- According to Business Quant data, Tax Provisions over the past three periods registered -$585000.0, $35000.0, and $131000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn | 372.00 Mn |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn | 105.00 Mn |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn | 575.00 Mn |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn | -176.00 Mn |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn | 78.30 Mn |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn | 70.00 Mn |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn | 94.00 Mn |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | -51.51 Mn |
| 10 | Trinity Biotech | 105.28 Mn | 100.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -585,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Jun 30, 2024 | 131,000.00 |
| Mar 31, 2024 | -67,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | -222,000.00 |
| Jun 30, 2023 | 267,000.00 |
| Mar 31, 2023 | 11,000.00 |
| Dec 31, 2022 | 13,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 32,000.00 |
| Mar 31, 2022 | 150,000.00 |
| Dec 31, 2021 | 1.19 Mn |
| Sep 30, 2021 | -251,000.00 |
| Jun 30, 2021 | -655,000.00 |
| Mar 31, 2021 | -105,000.00 |
| Dec 31, 2020 | 730,000.00 |
| Sep 30, 2020 | -387,000.00 |
| Jun 30, 2020 | -32,000.00 |
| Mar 31, 2020 | -129,000.00 |